The following forms are currently being revised / developed. Check back for new forms, and updates to the anticipated release dates.
| Forms | Anticipated Release Date | Notes |
|---|---|---|
| Recipient Contact Information (2820) | Summer 2019 | |
| Inotuzumab Ozogamicin (2541) | Summer 2019 | |
| BMT CTN 1702 Adverse Event Form (2535) | Summer 2019 | new study specific form |
| BMT CTN 1702 Off Study Form (2536) | Summer 2019 | new study specific form |
| BMT CTN 1702 Protocol Deviation / Violation Form (2537) | Summer 2019 | new study specific form |
| Pre-TED (2400) | Fall 2019 | Currently being reviewed / revised. |
| Disease Classification (2402) | Fall 2019 | Currently being reviewed / revised. |
| Baseline (2000) | Fall 2019 | Currently being reviewed / revised. |
| HCT Product and Infusion (2006) | Fall 2019 | Currently being reviewed / revised. |
| Confirmation of HLA typing form (2005) | Fall 2019 | Currently being reviewed / revised. |
| Infectious disease markers (2004) | Fall 2019 | Currently being reviewed / revised. |
| Post-TED (2450) | Fall 2019 | Currently being reviewed / revised. |
| Multiple Myeloma / PCD Pre-Infusion Form (2016) | Fall 2019 | underwent complete revision |
| Multiple Myeloma / PCD Post-Infusion Form (2116) | Fall 2019 | underwent complete revision |
For more information about the forms, or revision schedule, email cibmtrformfeedback@nmdp.org.
Last modified:
2019/07/03
Post your comment on this topic.